Valuation (19%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.53 | -23.05 |
| PEG Ratio (TTM) | -0.02 | 15.47 |
| P/S Ratio (TTM) | 22.60 | 49.46 |
| P/B Ratio (TTM) | 0.59 | 18.87 |
| P/FCF Ratio (TTM) | -0.44 | -3.27 |
| Price to 5YR AVG Earnings Ratio | 0.00 | -3.55 |
| Price to 5YR AVG FCF Ratio | -0.68 | -9.37 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -59.19% | -5.14% |
| ROE (TTM) | -112.11% | 16.69% |
| Net Profit Margin (TTM) | -5,374.75% | -1,583.93% |
| ROIC 5YR AVG | -5.72% | 15.15% |
Growth (10%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 28.15% | -73,381,762.02% | -44,029,027.03% |
| Revenue | -25.00% | -33.33% | -20.00% |
| Net Income | 0.97% | -168.71% | -101.74% |
| Cash Flow | -28.38% | -83.66% | -58.35% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.35 | 6.13 |
| Quick Ratio (TTM) | 3.35 | 5.85 |
| D/E Ratio (TTM) | 0.43 | -15.81 |
| Interest Coverage (TTM) | -40.12 | -1.57 |
| Piotroski F-Score | 2 | 5 |
| Altman Z-Score | N/A | 14.12 |
| LTL to 5YR AVG FCF | 0.00 | 0.17 |
| Shares Outstanding Growth 5YR AVG | 409.80% | 123.44% |